$LIVN
LivaNova PLC Stock $livn

$livn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000163969123000047 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$293.9M	$263.4M	$240.2M
YoY Change	15.63%	9.68%	-3.0%
Cost Of Revenue	$88.69M	$89.34M	$71.73M
YoY Change	27.05%	24.54%	-14.8%
Gross Profit	$205.2M	$174.1M	$168.4M
YoY Change	11.31%	3.35%	3.08%
Gross Profit Margin	69.82%	66.09%	70.13%
Selling, General & Admin	$125.9M	$124.1M	$118.5M
YoY Change	8.06%	4.73%	2.46%
% of Gross Profit	61.34%	71.3%	70.37%
Research & Development	$51.12M	$49.99M	$40.92M
YoY Change	49.36%	22.16%	-8.31%
% of Gross Profit	24.91%	28.71%	24.29%
Depreciation & Amortization	$12.48M	$5.956M	$5.626M
YoY Change	4.65%	5.87%	-7.45%
% of Gross Profit	6.08%	3.42%	3.34%
Operating Expenses	$187.8M	$174.1M	$159.4M
YoY Change	24.62%	9.2%	-0.54%
Operating Profit	$17.38M	-$2.342M	$9.505M
YoY Change	-45.28%	-124.64%	-266.81%
Interest Expense	$509.0K	$13.44M	$7.840M
YoY Change	-96.46%	71.39%	-50.8%
% of Operating Profit	2.93%		82.48%
Other Income/Expense, Net	-$12.61M	-$222.0K	-$35.00K
YoY Change	5477.43%	534.29%	-318.75%
Pretax Income	$5.280M	$9.768M	$5.569M
YoY Change	-72.21%	75.4%	-119.83%
Income Tax	$4.097M	$2.371M	$2.537M
% Of Pretax Income	77.59%	24.27%	45.56%
Net Earnings	$1.155M	$7.370M	$2.993M
YoY Change	-92.98%	146.24%	-109.73%
Net Earnings / Revenue	0.39%	2.8%	1.25%
Basic Earnings Per Share	$0.02	$0.14	$0.06
Diluted Earnings Per Share	$0.02	$0.14	$0.06
COMMON SHARES
Basic Shares Outstanding	53.77M shares	53.56M shares	53.30M shares
Diluted Shares Outstanding	53.98M shares	53.90M shares	54.18M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$222.9M	$214.3M	$128.7M
YoY Change	104.49%	66.49%	-49.2%
Cash & Equivalents	$222.9M	$214.3M	$128.7M
Short-Term Investments
Other Short-Term Assets	$376.6M	$367.9M	$383.9M
YoY Change	2.74%	-4.17%	190.86%
Inventory	$156.4M	$142.5M	$114.8M
Prepaid Expenses
Receivables	$185.9M	$178.3M	$182.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$941.8M	$903.0M	$809.6M
YoY Change	22.01%	11.54%	17.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.7M	$149.1M	$148.0M
YoY Change	28.21%	0.75%	-6.29%
Goodwill	$779.2M	$774.4M	$896.6M
YoY Change	-13.23%	-13.62%	-1.47%
Intangibles	$357.4M	$364.1M	$390.5M
YoY Change	-8.21%	-6.76%	-7.88%
Long-Term Investments	$21.73M	$21.47M	$16.75M
YoY Change	55.57%	28.22%	4883.63%
Other Assets	$57.63M	$13.95M	$17.92M
YoY Change	236.14%	-22.15%	44.54%
Total Long-Term Assets	$1.400B	$1.392B	$1.607B
YoY Change	-10.52%	-13.4%	-4.25%
TOTAL ASSETS
Total Short-Term Assets	$941.8M	$903.0M	$809.6M
Total Long-Term Assets	$1.400B	$1.392B	$1.607B
Total Assets	$2.342B	$2.295B	$2.417B
YoY Change	0.23%	-5.05%	2.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.21M	$75.73M	$73.92M
YoY Change	5.2%	2.45%	18.37%
Accrued Expenses	$127.1M	$96.35M	$92.03M
YoY Change	51.34%	4.7%	-0.01%
Deferred Revenue	$11.04M	$11.72M	$8.722M
YoY Change	21.38%	34.35%	-5.54%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$19.07M	$21.56M	$1.729M
YoY Change	495.13%	1146.79%	-77.54%
Total Short-Term Liabilities	$288.2M	$316.1M	$307.9M
YoY Change	9.2%	2.67%	4.25%
LONG-TERM LIABILITIES
Long-Term Debt	$568.0M	$520.2M	$455.8M
YoY Change	23.52%	14.13%	-29.48%
Other Long-Term Liabilities	$235.9M	$46.27M	$49.77M
YoY Change	399.89%	-7.03%	7.44%
Total Long-Term Liabilities	$803.9M	$566.5M	$505.6M
YoY Change	58.56%	12.04%	-27.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$288.2M	$316.1M	$307.9M
Total Long-Term Liabilities	$803.9M	$566.5M	$505.6M
Total Liabilities	$1.101B	$1.068B	$1.125B
YoY Change	4.43%	-5.11%	-13.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$975.5M	-$976.7M	-$894.8M
YoY Change	11.06%	9.15%	14.41%
Common Stock	$2.252B	$2.245B	$2.203B
YoY Change	1.63%	1.9%	19.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$95.00K	$319.0K	$619.0K
YoY Change	-76.07%	-48.47%	-22.43%
Treasury Stock Shares			327.7K shares
Shareholders Equity	$1.241B	$1.227B	$1.292B
YoY Change
Total Liabilities & Shareholders Equity	$2.342B	$2.295B	$2.417B
YoY Change	0.23%	-5.05%	2.01%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.155M	$7.370M	$2.993M
YoY Change	-92.98%	146.24%	-109.73%
Depreciation, Depletion And Amortization	$12.48M	$5.956M	$5.626M
YoY Change	4.65%	5.87%	-7.45%
Cash From Operating Activities	-$17.94M	$20.76M	$25.82M
YoY Change	75.11%	-19.62%	32.56%
INVESTING ACTIVITIES
Capital Expenditures	$5.659M	$7.685M	$5.215M
YoY Change	-192.36%	47.36%	-36.56%
Acquisitions
YoY Change
Other Investing Activities	-$996.0K	-$1.337M	-$267.0K
YoY Change	-90.06%	400.75%
Cash From Investing Activities	-$6.655M	-$11.48M	-$5.482M
YoY Change	-58.79%	109.49%	-44.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$1.875M	$0.00
YoY Change
Cash From Financing Activities	36.01M	-$5.235M	$214.9M
YoY Change	-669.84%	-102.44%	-2680.18%
NET CHANGE
Cash From Operating Activities	-17.94M	$20.76M	$25.82M
Cash From Investing Activities	-6.655M	-$11.48M	-$5.482M
Cash From Financing Activities	36.01M	-$5.235M	$214.9M
Net Change In Cash	11.42M	$7.340M	$234.4M
YoY Change	-134.92%	-96.87%	-80097.27%
FREE CASH FLOW
Cash From Operating Activities	-$17.94M	$20.76M	$25.82M
Capital Expenditures	$5.659M	$7.685M	$5.215M
Free Cash Flow	-$23.60M	$13.07M	$20.61M
YoY Change	473.28%	-36.57%	83.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001639691
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37599
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	LivaNova PLC
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	X0
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1268150
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20 Eastbourne Terrace
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2023Q1	dei	Entity Address Country EntityAddressCountry	GB
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	W2 6LG
CY2023Q1	dei	Country Region CountryRegion	44
CY2023Q1	dei	City Area Code CityAreaCode	0
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	203 325-0660
CY2023Q1	dei	Security12b Title Security12bTitle	Ordinary Shares - £1.00 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	LIVN
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53768134	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263418000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240175000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	89335000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71732000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	174083000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	168443000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124129000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	118525000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49986000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40918000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2310000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	505000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2342000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9505000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13437000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	7840000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2022Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	3904000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9768000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5569000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2371000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2537000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-27000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-39000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2993000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53617000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53300000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53900000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54176000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2993000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-966000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent	-695000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-966000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-695000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	8053000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-8260000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8955000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14457000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5962000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214340000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	308618000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11487000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11862000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	178318000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183110000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	142453000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	129379000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	24342000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	31708000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34946000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26321000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	903017000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	886136000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149060000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147187000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	774447000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	768787000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	364056000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	368559000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	36339000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35830000	usd
CY2023Q1	us-gaap	Investments Investments	21471000	usd
CY2022Q4	us-gaap	Investments Investments	16266000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1533000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1384000	usd
CY2023Q1	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	31014000	usd
CY2022Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	54393000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13951000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16231000	usd
CY2023Q1	us-gaap	Assets Assets	2294888000	usd
CY2022Q4	us-gaap	Assets Assets	2294773000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	22297000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	23434000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	75730000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74310000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	96353000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81481000	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	19311000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	29481000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	22279000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	16505000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	80159000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	72187000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	316129000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	297398000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	520201000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518067000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	90119000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	85292000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8627000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8516000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28782000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29548000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	16134000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	16804000	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	41285000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	85675000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	46270000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45849000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1067547000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1087149000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53854241	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53763715	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53851979	shares
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53564664	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	82424000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	82424000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2162928000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2157724000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41032000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-48119000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-976660000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-984030000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	90526	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	287315	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	319000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	375000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1227341000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2294888000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2294773000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2993000	usd
CY2023Q1	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	26281000	usd
CY2022Q1	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	1355000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10579000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10256000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6355000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6465000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	5956000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	5626000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5019000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4412000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4827000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3773000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2642000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2653000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	184000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1073000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7558000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1494000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11342000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9637000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3838000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1953000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	21378000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9957000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	972000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	709000	usd
CY2023Q1	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-10254000	usd
CY2022Q1	livn	Increase Decrease In Litigation Reserve IncreaseDecreaseInLitigationReserve	-3097000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20757000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25823000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7685000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5215000	usd
CY2023Q1	livn	Purchases Of Investments PurchasesOfInvestments	5136000	usd
CY2022Q1	livn	Purchases Of Investments PurchasesOfInvestments	278000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1337000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-11000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11484000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5482000	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	1974000	usd
CY2022Q1	us-gaap	Repayments Of Short Term Debt Maturing In More Than Three Months RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1875000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1577000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1074000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	218342000	usd
CY2023Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
CY2022Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	2426000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	191000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	35000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5235000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	214877000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3302000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-826000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7340000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	234392000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515618000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207992000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	522958000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	442384000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsThe Company has reclassified certain prior period amounts on the condensed consolidated balance sheets for comparative purposes. These reclassifications did not have a material effect on LivaNova’s financial condition.
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	15586000	usd
CY2023Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	16791000	usd
CY2023Q1	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	32377000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5260000	usd
CY2021Q1	livn	Utilities Operating Expense Environmental Maintenance UtilitiesOperatingExpenseEnvironmentalMaintenance	1000000	eur
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	541758000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	538959000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	21557000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20892000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	520201000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	518067000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	308600000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301400000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	31914000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	42521000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	55726000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	91561000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	19311000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	3059000	usd
CY2016Q2	livn	Reimbursed Legal Fees ReimbursedLegalFees	292000	eur
CY2023Q1	livn	Reimbursed Legal Fees ReimbursedLegalFees	318062000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	7370000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1227341000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1294645000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3171000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2993000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8955000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1291854000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	7620000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	7620000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	533000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	533000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7087000	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-8902000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-8902000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	53000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	53000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8955000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	100000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.243
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.456
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	usd
CY2023Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1000000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53617000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53300000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	283000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	876000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53900000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54176000	shares
CY2023Q1	livn	Number Of Geographic Regions In Which Entity Operates NumberOfGeographicRegionsInWhichEntityOperates	3	geographic_region
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263418000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240175000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13437000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	7840000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2022Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	3904000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9768000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5569000	usd
CY2023Q1	us-gaap	Assets Assets	2294888000	usd
CY2022Q4	us-gaap	Assets Assets	2294773000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15500000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	768787000	usd
CY2023Q1	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	5660000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	774447000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	149060000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147187000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	80054000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	70027000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18500000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15508000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43899000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43844000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	142453000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	129379000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10000000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8200000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	15403000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8653000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11718000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10226000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9992000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9379000	usd
CY2023Q1	livn	Interest Payable Current Net InterestPayableCurrentNet	8379000	usd
CY2022Q4	livn	Interest Payable Current Net InterestPayableCurrentNet	-76000	usd
CY2023Q1	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	7667000	usd
CY2022Q4	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	7020000	usd
CY2023Q1	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	6960000	usd
CY2022Q4	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	6414000	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3816000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3950000	usd
CY2023Q1	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	2428000	usd
CY2022Q4	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	1678000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1236000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5886000	usd
CY2023Q1	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	798000	usd
CY2022Q4	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	2045000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	27956000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26306000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	96353000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81481000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14100000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	222000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2791000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	4536000	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	20000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-222000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-35000	usd
CY2023Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	25547000	usd
CY2022Q1	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	3904000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214340000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214172000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	308618000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	301446000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	522958000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515618000	usd

Files In Submission

Name	View Source	Status
0001639691-23-000047-index-headers.html	Edgar Link	pending
0001639691-23-000047-index.html	Edgar Link	pending
0001639691-23-000047.txt	Edgar Link	pending
0001639691-23-000047-xbrl.zip	Edgar Link	pending
finalpsudoubletriggeragr.htm	Edgar Link	pending
finalpsudoubletriggeragr001.jpg	Edgar Link	pending
finalpsudoubletriggeragr002.jpg	Edgar Link	pending
finalpsudoubletriggeragr003.jpg	Edgar Link	pending
finalpsudoubletriggeragr004.jpg	Edgar Link	pending
finalpsudoubletriggeragr005.jpg	Edgar Link	pending
finalpsudoubletriggeragr006.jpg	Edgar Link	pending
finalpsudoubletriggeragr007.jpg	Edgar Link	pending
finalpsudoubletriggeragr008.jpg	Edgar Link	pending
finalpsudoubletriggeragr009.jpg	Edgar Link	pending
finalpsudoubletriggeragr010.jpg	Edgar Link	pending
finalpsudoubletriggeragr011.jpg	Edgar Link	pending
finalpsudoubletriggeragr012.jpg	Edgar Link	pending
finalpsudoubletriggeragr013.jpg	Edgar Link	pending
finalpsudoubletriggeragr014.jpg	Edgar Link	pending
finalpsudoubletriggeragr015.jpg	Edgar Link	pending
finalpsudoubletriggeragr016.jpg	Edgar Link	pending
finalpsudoubletriggeragr017.jpg	Edgar Link	pending
finalpsudoubletriggeragr018.jpg	Edgar Link	pending
finalpsudoubletriggeragr019.jpg	Edgar Link	pending
finalpsudoubletriggeragr020.jpg	Edgar Link	pending
finalpsudoubletriggeragr021.jpg	Edgar Link	pending
finalpsudoubletriggeragr022.jpg	Edgar Link	pending
finalpsudoubletriggeragr023.jpg	Edgar Link	pending
finalpsudoubletriggeragr024.jpg	Edgar Link	pending
finalpsudoubletriggeragr025.jpg	Edgar Link	pending
finalpsudoubletriggeragr026.jpg	Edgar Link	pending
finalpsudoubletriggeragr027.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
finalpsudoubletriggeragr028.jpg	Edgar Link	pending
finalpsudoubletriggeragr029.jpg	Edgar Link	pending
finalrsudoubletriggeragr.htm	Edgar Link	pending
finalrsudoubletriggeragr001.jpg	Edgar Link	pending
finalrsudoubletriggeragr002.jpg	Edgar Link	pending
finalrsudoubletriggeragr003.jpg	Edgar Link	pending
finalrsudoubletriggeragr004.jpg	Edgar Link	pending
finalrsudoubletriggeragr005.jpg	Edgar Link	pending
finalrsudoubletriggeragr006.jpg	Edgar Link	pending
finalrsudoubletriggeragr007.jpg	Edgar Link	pending
finalrsudoubletriggeragr008.jpg	Edgar Link	pending
finalrsudoubletriggeragr009.jpg	Edgar Link	pending
finalrsudoubletriggeragr010.jpg	Edgar Link	pending
finalrsudoubletriggeragr011.jpg	Edgar Link	pending
finalrsudoubletriggeragr012.jpg	Edgar Link	pending
finalrsudoubletriggeragr013.jpg	Edgar Link	pending
finalrsudoubletriggeragr014.jpg	Edgar Link	pending
finalrsudoubletriggeragr015.jpg	Edgar Link	pending
finalrsudoubletriggeragr016.jpg	Edgar Link	pending
finalrsudoubletriggeragr017.jpg	Edgar Link	pending
finalrsudoubletriggeragr018.jpg	Edgar Link	pending
finalrsudoubletriggeragr019.jpg	Edgar Link	pending
finalrsudoubletriggeragr020.jpg	Edgar Link	pending
finalrsudoubletriggeragr021.jpg	Edgar Link	pending
finalrsudoubletriggeragr022.jpg	Edgar Link	pending
finalrsudoubletriggeragr023.jpg	Edgar Link	pending
finalrsudoubletriggeragr024.jpg	Edgar Link	pending
finalrsudoubletriggeragr025.jpg	Edgar Link	pending
finalrsudoubletriggeragr026.jpg	Edgar Link	pending
finalrsudoubletriggeragr027.jpg	Edgar Link	pending
finalrsudoubletriggeragr028.jpg	Edgar Link	pending
finalrsudoubletriggeragr029.jpg	Edgar Link	pending
finalrsudoubletriggeragr030.jpg	Edgar Link	pending
finalsardoubletriggeragr.htm	Edgar Link	pending
finalsardoubletriggeragr001.jpg	Edgar Link	pending
finalsardoubletriggeragr002.jpg	Edgar Link	pending
finalsardoubletriggeragr003.jpg	Edgar Link	pending
finalsardoubletriggeragr004.jpg	Edgar Link	pending
finalsardoubletriggeragr005.jpg	Edgar Link	pending
finalsardoubletriggeragr006.jpg	Edgar Link	pending
finalsardoubletriggeragr007.jpg	Edgar Link	pending
finalsardoubletriggeragr008.jpg	Edgar Link	pending
finalsardoubletriggeragr009.jpg	Edgar Link	pending
finalsardoubletriggeragr010.jpg	Edgar Link	pending
finalsardoubletriggeragr011.jpg	Edgar Link	pending
finalsardoubletriggeragr012.jpg	Edgar Link	pending
finalsardoubletriggeragr013.jpg	Edgar Link	pending
finalsardoubletriggeragr014.jpg	Edgar Link	pending
finalsardoubletriggeragr015.jpg	Edgar Link	pending
finalsardoubletriggeragr016.jpg	Edgar Link	pending
finalsardoubletriggeragr017.jpg	Edgar Link	pending
finalsardoubletriggeragr018.jpg	Edgar Link	pending
finalsardoubletriggeragr019.jpg	Edgar Link	pending
finalsardoubletriggeragr020.jpg	Edgar Link	pending
finalsardoubletriggeragr021.jpg	Edgar Link	pending
finalsardoubletriggeragr022.jpg	Edgar Link	pending
finalsardoubletriggeragr023.jpg	Edgar Link	pending
finalsardoubletriggeragr024.jpg	Edgar Link	pending
finalsardoubletriggeragr025.jpg	Edgar Link	pending
finalsardoubletriggeragr026.jpg	Edgar Link	pending
finalsardoubletriggeragr027.jpg	Edgar Link	pending
finalsardoubletriggeragr028.jpg	Edgar Link	pending
finalsardoubletriggeragr029.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
livn-20230331.htm	Edgar Link	pending
livn-20230331.xsd	Edgar Link	pending
livn-20230331_g1.jpg	Edgar Link	pending
livn-2023331xex311.htm	Edgar Link	pending
livn-2023331xex312.htm	Edgar Link	pending
livn-2023331xex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
livn-20230331_pre.xml	Edgar Link	unprocessable
livn-20230331_lab.xml	Edgar Link	unprocessable
livn-20230331_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
livn-20230331_cal.xml	Edgar Link	unprocessable
livn-20230331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIVN
LivaNova PLC Stock $livn

2023 Q2 Form 10-Q Financial Statement

#000163969123000047 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN LivaNova PLC Stock $livn

2023 Q2 Form 10-Q Financial Statement

#000163969123000047 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN
LivaNova PLC Stock $livn